Harvard Bioscience Inc (HBIO)
3.70
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
3.66
-0.04
(-1.08%)
After-Hours: 20:00
Harvard Bioscience Research and Development Expense (Quarterly): 3.15M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.15M |
| September 30, 2023 | 2.76M |
| June 30, 2023 | 2.957M |
| March 31, 2023 | 2.897M |
| December 31, 2022 | 2.849M |
| September 30, 2022 | 2.763M |
| June 30, 2022 | 3.497M |
| March 31, 2022 | 3.22M |
| December 31, 2021 | 2.951M |
| September 30, 2021 | 2.66M |
| June 30, 2021 | 2.701M |
| March 31, 2021 | 2.487M |
| December 31, 2020 | 2.349M |
| September 30, 2020 | 1.949M |
| June 30, 2020 | 1.897M |
| March 31, 2020 | 2.49M |
| December 31, 2019 | 2.645M |
| September 30, 2019 | 2.564M |
| June 30, 2019 | 2.771M |
| March 31, 2019 | 2.735M |
| December 31, 2018 | 3.045M |
| September 30, 2018 | 2.783M |
| June 30, 2018 | 2.758M |
| March 31, 2018 | 2.402M |
| December 31, 2017 | 1.526M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.538M |
| June 30, 2017 | 1.296M |
| March 31, 2017 | 1.285M |
| December 31, 2016 | 1.156M |
| September 30, 2016 | 1.309M |
| June 30, 2016 | 1.502M |
| March 31, 2016 | 1.425M |
| December 31, 2015 | 1.532M |
| September 30, 2015 | 1.426M |
| June 30, 2015 | 1.714M |
| March 31, 2015 | 1.748M |
| December 31, 2014 | 1.564M |
| September 30, 2014 | 1.059M |
| June 30, 2014 | 1.284M |
| March 31, 2014 | 0.973M |
| December 31, 2013 | 1.118M |
| September 30, 2013 | 1.101M |
| June 30, 2013 | 0.922M |
| March 31, 2013 | 1.013M |
| December 31, 2012 | -1.205M |
| September 30, 2012 | 1.861M |
| June 30, 2012 | 1.972M |
| March 31, 2012 | 1.714M |
| December 31, 2011 | -0.074M |
| September 30, 2011 | 1.554M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.897M
Minimum
Jun 2020
3.497M
Maximum
Jun 2022
2.714M
Average
2.76M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp | 83.50M |
| Azenta Inc | 8.493M |
| Bionano Genomics Inc | 11.70M |
| Akoya Biosciences Inc | 4.67M |
| Singular Genomics Systems Inc | 11.69M |